Both in Biotechnology
Immunovant vs Krystal Biotech
Over the past year IMVT returned +47.6% and KRYS returned +68.9%; their daily moves had a correlation of 0.32.
IMVT +47.6% KRYS +68.9%Growth of $1, one year, split-adjusted
| Metric | IMVT | KRYS |
|---|---|---|
| Price | $28.38 | $322.17 |
| Market cap | $5.86B | $9.54B |
| Today | −0.73% | −1.00% |
| 1 month | −23.9% | −8.2% |
| 6 months | −3.8% | +16.8% |
| Year to date | +11.6% | +30.7% |
| 1 year | +47.7% | +64.4% |
| Revenue growth (YoY) | — | +24.1% |
| Gross margin | — | 94.6% |
| Net margin | — | 45.9% |
| P/E (TTM) | — | 39.5× |
| Price / sales | — | 21.6× |
| Net cash | $797.8M | $845.6M |
| Dividend yield | — | — |
| Volatility (60d) | 36.3% | 38.2% |
| Short % of float | 20.1% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).